| 产品详情 |
| Edit |   |
|---|
| Product Name | Eliglustat |
|---|
| Description | MW: 404.54. Purity ≥98% by HPLC. Eliglustat is a potent and specific inhibitor of glucosylceramide synthase. Eliglustat is a new promising substrate reduction therapy (SRT) for Gaucher disease (GD). Eliglustat works by inhibiting UDP-glucosylceramide synthase; the first enzyme that catalyzes the biosynthesis of glycosphingolipids; thus reducing the load of glucosylceramide influx into the lysosome. |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [N- ( (1R; 2R)-1- (2; 3-dihydrobenzo[b][1; 4]dioxin-6-yl)-1-hydroxy-3- (pyrrolidin-1-yl) propan-2-yl) octanamide hemi ( (2R; 3R)-2; 3-dihydroxysuccinate); Genz99067] |
|---|
| Gene, Accession, CAS # | CAS: 491833-29-5 |
|---|
| Catalog # | MBS846359 |
|---|
| Price | |
|---|
| Order / More Info | Eliglustat from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|